Porth Ymchwil

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. / Sandoo, A.A.; Dimitroulas, T.; Sandoo, A. et al.
Yn: Atherosclerosis, Cyfrol 237, Rhif 1, 27.08.2014.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Sandoo, AA, Dimitroulas, T, Sandoo, A, Hodson, J, Smith, J, Panoulas, VF & Kitas, GD 2014, 'Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis', Atherosclerosis, cyfrol. 237, rhif 1. https://doi.org/10.1016/j.atherosclerosis.2014.07.033

APA

Sandoo, A. A., Dimitroulas, T., Sandoo, A., Hodson, J., Smith, J., Panoulas, V. F., & Kitas, G. D. (2014). Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Atherosclerosis, 237(1). https://doi.org/10.1016/j.atherosclerosis.2014.07.033

CBE

Sandoo AA, Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF, Kitas GD. 2014. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Atherosclerosis. 237(1). https://doi.org/10.1016/j.atherosclerosis.2014.07.033

MLA

Sandoo, A.A. et al. "Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis". Atherosclerosis. 2014. 237(1). https://doi.org/10.1016/j.atherosclerosis.2014.07.033

VancouverVancouver

Sandoo AA, Dimitroulas T, Sandoo A, Hodson J, Smith J, Panoulas VF et al. Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Atherosclerosis. 2014 Awst 27;237(1). doi: 10.1016/j.atherosclerosis.2014.07.033

Author

Sandoo, A.A. ; Dimitroulas, T. ; Sandoo, A. et al. / Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis. Yn: Atherosclerosis. 2014 ; Cyfrol 237, Rhif 1.

RIS

TY - JOUR

T1 - Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis

AU - Sandoo, A.A.

AU - Dimitroulas, T.

AU - Sandoo, A.

AU - Hodson, J.

AU - Smith, J.

AU - Panoulas, V.F.

AU - Kitas, G.D.

PY - 2014/8/27

Y1 - 2014/8/27

N2 - The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).

AB - The aim of our study was to determine whether Dimethylarginine Dimethylaminohydrolase (DDAH) 1 and 2 gene polymorphisms – the main enzyme involved in ADMA degradation – are associated with high Asymmetric Dimethylarginine (ADMA) levels in Rheumatoid Arthritis (RA).

U2 - 10.1016/j.atherosclerosis.2014.07.033

DO - 10.1016/j.atherosclerosis.2014.07.033

M3 - Article

VL - 237

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -